MERCK & CO., INC. (MRK)
Clinical trial NCT07286149: completion date: 2037-05-06 → 2032-04-13.
Clinical trial NCT07286149: completion date: 2037-05-06 → 2032-04-13.
Clinical trial NCT07061288: enrollment: 48 → 116 participants.
Clinical trial NCT06471829: completion date: 2027-11-30 → 2027-10-31.
Clinical trial NCT07583563 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-05
Clinical trial NCT07425054: start date: 2026-03-01 → 2026-06-01.
Clinical trial NCT07602283 updates: 1. start date: 2026-06-01 → 2026-06-09 2. collaborators removed: Yale University School of Medicine, Department of Psychiatry
Clinical trial NCT07547436: start date: 2026-06-15 → 2026-06-08.
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)
Clinical trial NCT06188208 updates: 1. completion date: 2025-12-21 → 2026-02-20 2. primary completion date: 2025-12-21 → 2026-02-20
Clinical trial NCT07577817: status: NOT_YET_RECRUITING → RECRUITING.